We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IX:NYSEORIX Corporation Analysis

Data as of 2026-04-11 - not real-time

$31.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

ORIX Corporation is trading near a key technical support level, with the short‑term moving average sitting below the longer‑term average, suggesting a potential bounce. The relative strength index hovers around the neutral zone, while the MACD histogram shows a modest bullish tilt, indicating modest upward momentum. Volatility remains elevated, but the beta is comfortably below the market, tempering systematic risk.
Fundamentally, the stock appears undervalued relative to its peers, with a price‑to‑earnings multiple well beneath the sector average and a price‑to‑book ratio close to one. A healthy dividend yield coupled with a moderate payout ratio points to sustainable income. Recent analyst upgrades driven by improving earnings estimates add further optimism, and the upside potential implied by the price target exceeds the current level, making the stock an attractive candidate for income‑focused and value‑oriented investors.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Technical support near current price
  • Bullish MACD signal
  • Analyst upgrade reflecting earnings momentum

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Valuation discount to industry peers
  • Sustainable dividend yield
  • Continued earnings growth expectations

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Stable cash generation and asset base
  • Diversified global operations reducing concentration risk
  • Attractive dividend profile supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth12.50%
Profit Margin15.00%
P/E Ratio11.8
ROE10.69%
ROA2.29%
Debt/Equity142.12
P/B Ratio1.2
Industry P/E17.1

Technical Analysis

TrendNeutral
RSI51.7
Support$29.04
Resistance$31.61
MA 20$30.11
MA 50$32.09
MA 200$27.60
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09

Valuation

Target Price$34.66
Upside/Downside11.81%
GradeUndervalued
TypeBlend
Dividend Yield3.23%

Risk Assessment

Beta0.82
Volatility35.63%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.